[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352406-105":59,"doc-detail-352406-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","prostate-cancer-dissecting-novel-immunosuppressive-mechanisms-through-context-specific-transcriptomic-programs-and-mdsc-cells","Prostate Cancer - Dissecting Novel Immunosuppressive Mechanisms Through Context-Specific Transcriptomic Programs and MDSC Cells","","Prostate cancer remains largely refractory to immunotherapy, suggesting that immune landscapes can be context specific and differ between circulation and tumor. The study integrates bulk RNA sequencing from PBMCs, primary prostate tissue, and biochemical-recurrence tumors with multiparameter flow cytometry, UMAP/T-REX mapping, and de novo lncRNA discovery to define context-specific immunoregulation. PBMCs show an IL-1/TNF/IL-17 inflammatory architecture with chemotactic programs and low-density PMN-MDSC–like signals, whereas tumors repress chemokines and innate mediators while elevating prostate cancer–associated lncRNAs, linking immune quiescence with regulatory non-coding programs.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prostate-cancer-dissecting-novel-immunosuppressive-mechanisms-through-context-specific-transcriptomic-programs-and-mdsc-cells/352406/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prostate-cancer-dissecting-novel-immunosuppressive-mechanisms-through-context-specific-transcriptomic-programs-and-mdsc-cells/352406.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is prostate cancer resistant to immunotherapy in this study’s framing?","Question",{"text":112,"@type":113},"The study argues that prostate cancer remains largely refractory, implying immune landscape programs are context specific and can diverge between circulation and tumor.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were context-specific immunoregulation programs characterized?",{"text":117,"@type":113},"They were characterized by integrating bulk RNA sequencing across multiple patient cohorts with multiparameter flow cytometry, UMAP/T-REX mapping, and de novo long non-coding RNA discovery.",{"name":119,"@type":110,"acceptedAnswer":120},"What key immune differences did the study observe between PBMCs and tumors?",{"text":121,"@type":113},"PBMCs displayed a coherent IL-1/TNF/IL-17 inflammatory architecture with chemotactic programs and PMN-MDSC–like signals, while tumors broadly repressed chemokines and innate immune mediators but upregulated prostate cancer–associated lncRNAs.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352406,1790184205,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Article  \nProstate Cancer: Dissecting Novel Immunosuppressive Mechanisms Through Context-Specific Transcriptomic Programs and MDSC Cells  \nPedro Reyes Martinez 1,2,3, Erick Sierra Diaz 2, Fabiola Solorzano Ibarra 4, Jorge Raul Vazquez Urrutia 5, José de Jesús Guerrero García 6, Martha Cecilia Téllez Bañuelos 7, Julio Enrique Castañeda Delgado 8,9, Karina Sanchez Reyes 10 and Pablo Cesar Ortiz Lazareno 3, *  \nAcademic Editor: Giuseppe Lucarelli  \nReceived: 19 December 2025  \nRevised: 28 January 2026  \nAccepted: 28 January 2026  \nPublished: 3 February 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Doctorado en Ciencias Biomédicas, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44350, Mexico; [pedro.reyesm97@gmail.com](pedro.reyesm97@gmail.com)  \n2 División de Epidemiología, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44329, Mexico; [erksland@gmail.com](erksland@gmail.com)  \n3 División de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Mexico  \n4 Estancias Posdoctorales Secihti, Guadalajara 44340, Mexico; [fabiolasolorzanoibarra@gmail.com](fabiolasolorzanoibarra@gmail.com)  \n5 Department of Medicine, The Pennsylvania State University College of Medicine, The Pennsylvania State University, Hershey, PA 17033, USA; [jvazquezurrutia@pennstatehealth.psu.edu](jvazquezurrutia@pennstatehealth.psu.edu)  \n6 Banco de Sangre Central, Unidad Médica de Alta Especialidad (UMAE), Hospital de Especialidades (HE), Centro Médico Nacional de Occidente (CMNO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44329, Mexico; [jg1@gmail.com](jg1@gmail.com)  \n7 Laboratorio de Inmunología Traslacional, Departamento de Biología Celular y Molecular, Centro Universitario de Ciencias Biológicas y Agropecuarias, Universidad de Guadalajara, Zapopan 45200, Mexico; [martha.tellez@academicos.udg.mx](martha.tellez@academicos.udg.mx)  \n8 Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 98000, Mexico; [julioenriquecastaneda@gmail.com](julioenriquecastaneda@gmail.com)  \n9 Investigadores por México, Cátedras Secihti, Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano del Seguro Social (IMSS), Zacatecas 98000, Mexico  \n10 Departamento de Clínicas Médicas, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44350, Mexico; [karina.sanchez@academicos.udg.mx](karina.sanchez@academicos.udg.mx)  \n* [Correspondence: pablolazareno@gmail.com or pablo.ortiz@imss.gob.mx](Correspondence: pablolazareno@gmail.com or pablo.ortiz@imss.gob.mx); Tel.: +52-33-3444-0948  \nAbstract  \nProstate cancer remains largely refractory to immunotherapy, implying the existence of context-specific immune landscape programs that diverge between circulation and tumor. Here, we integrate bulk RNA sequencing from three cohorts (patient peripheral mononuclear cells, primary prostate tissue, and biochemical-recurrence tumors) with multiparameter flow cytometry, unsupervised UMAP/T-REX (Tracking Responders Expanding) mapping, and de novo discovery of long non-coding RNAs (lncRNAs) to characterize context-specific immunoregulation. Patient PBMCs revealed a coherent IL-1/TNF /IL-17 inflammatory architecture with strong chemotactic programs and an unexpected neutrophillike signal despite density-gradient isolation, consistent with low-density PMN-MDSCs. In contrast, tumors broadly repressed chemokines and innate immune mediators, yet upregulated prostate cancer-associated lncRNAs, indicating local immune quie","cbCaickxR3Ww5q8H","https://ap.wps.com/l/cbCaickxR3Ww5q8H","pdf",7916562,35,"English","# Abstract\n# Introduction\n# Methods and Data Integration\n## Bulk RNA Sequencing and Cohorts\n## Multiparameter Flow Cytometry and Mapping\n## lncRNA Discovery and Network Analysis\n# Results\n## PBMC Inflammatory Programs and PMN-MDSC–like Signals\n## Tumor Immune Quiescence and lncRNA Upregulation\n## EMT, Metabolic Remodeling, and Recurrence Signatures\n## High-Dimensional Cytometry and Myeloid Clusters\n## Structural Modeling of lncRNA Junctions","[{\"question\":\"Why is prostate cancer resistant to immunotherapy in this study’s framing?\",\"answer\":\"The study argues that prostate cancer remains largely refractory, implying immune landscape programs are context specific and can diverge between circulation and tumor.\"},{\"question\":\"How were context-specific immunoregulation programs characterized?\",\"answer\":\"They were characterized by integrating bulk RNA sequencing across multiple patient cohorts with multiparameter flow cytometry, UMAP/T-REX mapping, and de novo long non-coding RNA discovery.\"},{\"question\":\"What key immune differences did the study observe between PBMCs and tumors?\",\"answer\":\"PBMCs displayed a coherent IL-1/TNF/IL-17 inflammatory architecture with chemotactic programs and PMN-MDSC–like signals, while tumors broadly repressed chemokines and innate immune mediators but upregulated prostate cancer–associated lncRNAs.\"}]","Prostate Cancer - Dissecting Novel Immunosuppressive Mechanisms Through Context-Specific Transcriptomic Programs and MDSC Cells | PDF",1790099393,88,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49205cfb4356063170a5d9ac6cfe7e34.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/915d0712da656085f8b659da9f79b982.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/543a49d13536c840df0efae923c96749.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f4b0d3888bec17311eac007f69367b8.webp",980,1385]